BrightSpring Health Services recently released its 10-Q report for the quarter ended June 30, 2026. BrightSpring Health Services, Inc. operates a home* and community-based healthcare platform in the United States through two segments: Pharmacy Solutions and Provider Services. Its businesses deliver pharmacy, clinical, supportive care, home health, rehabilitation, and behavioral therapy services to Medicare, Medicaid, commercially insured, and other patients, with headquarters in Louisville, Kentucky.
In Item 2, management said the company serves more than 485,000 patients daily across all 50 states with about 12,700 clinical providers and pharmacists. It described the platform as focused on medically complex Senior and Specialty patients, with services delivered largely in lower-cost home and community settings. Management also noted that the company was founded in 1974 and formerly operated as Phoenix Parent Holdings Inc. before adopting the BrightSpring name in May 2021.
For the second quarter, BrightSpring reported revenue of $3.87 billion, up 23.0% from $3.15 billion a year earlier. Pharmacy Solutions generated $3.41 billion, up 22.1%, while Provider Services produced $466.0 million, up 30.3%. Net income rose to $86.6 million from $8.5 million, and adjusted EBITDA increased 44.2% to $205.5 million.
The company said Pharmacy Solutions accounted for 88.0% of second-quarter revenue, with Provider Services at 12.0%. Within Pharmacy Solutions, revenue reached $3.41 billion versus $2.79 billion a year earlier. Within Provider Services, revenue increased from $357.6 million to $466.0 million.
For the first six months, revenue totaled $7.49 billion, up from $6.03 billion. Pharmacy Solutions contributed $6.58 billion, and Provider Services contributed $908.4 million. The company said diluted EPS increased to $0.39 from $0.04, while adjusted EPS rose to $0.45 from $0.22.
Management highlighted a $300.0 million paydown and refinancing of its First Lien Facility, along with interest-rate changes that it said produced savings. It also completed a secondary stock offering in June 2026 and repurchased 1,026,465 shares for $60.0 million at $58.453 per share. At June 30, 2026, company leverage stood at 2.15x.
BrightSpring said its payor base remains diversified, with revenue coming mainly from commercial insurance, Medicaid, Medicare, and private and other payors. For the second quarter, consolidated revenue mix was 28.7% commercial insurance, 11.3% Medicaid, 8.0% Medicare Part A, 0.8% Medicare Part B, 18.6% Medicare Part C, 29.7% Medicare Part D, and 2.9% private and other. Today the company's shares have moved -15.51% to a price of $61.58. Check out the company's full 10-Q submission here.
